Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-08-22

Clinical Trial Update: HSV-2 Suppression to Reduce HIV-1 Levels in HIV-1 Co-infected Persons [Phase 3]

View source ↗

Summary

This update reports the completion of a Phase 3 trial testing whether HSV-2 suppression lowers HIV-1 viral levels in individuals co-infected with HIV-1 and herp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Washington | Conditions: HIV Infections, Herpes Simplex | Phase 3 | Status: COMPLETED